Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions

NCT02003040 is registered in ClinicalTrials.gov with Mespere Lifesciences Inc. as lead sponsor.

NCT NCT02003040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02003040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions
Lead sponsor
Mespere Lifesciences Inc.
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2014
Completion date
May 31, 2016
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhf